In addition, we also used RT-qPCR assay to analyse the regulatory effects of CKI on core genes (AKT1, CDK1, JAK1, EGFR, MAPK1 and MAPK3) to evaluate the mechanism of CKI in PC treatment. This evidence concerns the gene MAPK3 and pachyonychia congenita.